I would suggest small raise (<$5m in mid 30s), maybe potential placement to strategic holder, to take the company from Phase 1 towards Phase 2 expansion plan. Exciting indeed.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025